Strategy for Public Health Preparedness and Response to Artificial Intelligence Threats

Bill Number

S. 501

Origin Chamber

Senate

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-02-10: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Last Updated

2025-04-24T16:23:49Z

AI-Generated Summary

Purpose

This legislation aims to enhance U.S. public health security by requiring the Secretary of Health and Human Services (HHS) to create a comprehensive strategy for preparing for and responding to threats from the misuse of artificial intelligence (AI), particularly those that could harm national health, such as AI-enabled biological weapons or treatment-resistant pathogens.

Key Provisions

• Definitions:
• "Artificial intelligence" is defined as systems that perform tasks requiring human-like intelligence, based on a 2019 defense law.
• Terms like "qualified countermeasure" (tools to counter health threats), "security countermeasure" (defenses against chemical, biological, or radiological attacks), and "qualified pandemic or epidemic product" (medical products for outbreaks) are drawn from existing public health laws.
• "Secretary" refers to the head of HHS.

• Development of Strategy:
• Within 180 days of enactment, the HHS Secretary must consult with experts (e.g., those developing health countermeasures and AI technologies) and submit a strategy to relevant congressional committees.
• The strategy focuses on public health preparedness, response, and biodefense against AI misuse risks to national health security.

• Required Elements of the Strategy:
• A framework to mitigate AI misuse risks.
• Outlines HHS's duties, functions, and goals for preparation and response, including success metrics.
• Identifies gaps in current public health capabilities.
• Proposes ways to fill those gaps and strengthen emergency response.
• Specific mitigation strategies for AI threats, at minimum including:
• Development of biological weapons.
• Design of viruses or bacteria resistant to treatments.
• Covers other AI misuse risks as determined by HHS.

• Submission and Security:
• The strategy is shared with key congressional committees (e.g., Senate Health, Education, Labor, and Pensions; House Energy and Commerce) in a way that protects national security.

Significant Changes to Existing Law

• Amends Section 2811(b)(4)(D) of the Public Health Service Act (a key law for coordinating federal responses to health emergencies).
• Expands the scope of federal response coordination to explicitly include AI misuse threats as outlined in the new strategy.
• This integrates AI-specific preparedness into the broader "all-hazards" approach to public health emergencies (e.g., pandemics, bioterrorism), ensuring federal deployments address these risks alongside traditional threats.

Potential Impacts

• Government Agencies: HHS will gain formalized responsibilities and resources for AI-related biodefense, potentially increasing coordination with other agencies like the Department of Defense. This could lead to new funding requests or programs to address identified gaps.
• Citizens: Improves national readiness against emerging AI-driven health threats, potentially reducing risks from bioengineered diseases or attacks, though direct effects on individuals may be indirect through enhanced public health systems.
• International Relations: Strengthens U.S. biodefense posture, which could influence global AI governance discussions or collaborations on health security, but focuses domestically without direct foreign policy mandates.

Main Stakeholders Affected

• Federal Government: Primarily HHS (leads strategy development); congressional committees (receive and oversee the strategy); other agencies involved in health security (e.g., CDC, FDA).
• Private Sector: Developers of AI technologies and health countermeasures (e.g., biotech firms, pharmaceutical companies) consulted during strategy creation.
• Experts and Organizations: Public health stakeholders, AI researchers, and biodefense groups providing input.
• General Public: Indirectly benefits from improved preparedness against AI-exacerbated health risks.

Notable Legal, Constitutional, or Political Implications

• Legal: Builds on existing public health and defense frameworks without creating new regulatory powers; emphasizes consultation to ensure balanced input. The national security protection for the strategy aligns with classified information handling under federal law.
• Constitutional: No apparent conflicts; supports Congress's authority over interstate commerce and national defense, while advancing the government's role in public welfare.
• Political: Bipartisan sponsorship (Senators Budd and Markey) signals broad support for addressing AI risks in health policy. Could spur future legislation on AI ethics or funding, highlighting the growing intersection of technology and biodefense in national security debates.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Budd, Ted [R-NC]

Cosponsors (1)

Sen. Markey, Edward J. [D-MA]

Recent Actions

• 2025-02-10: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
• 2025-02-10: Introduced in Senate

Bill Versions

• Strategy for Public Health Preparedness and Response to Artificial Intelligence Threats — issued 2025-02-10 — PDF (5 pages)